PROPHYLAXIS IN OVARIAN-CANCER

被引:10
作者
BARBER, HRK [1 ]
机构
[1] CORNELL UNIV, MED CTR, COLL MED, NEW YORK, NY 10021 USA
关键词
PROPHYLAXIS; POSTMENOPAUSAL PALPABLE OVARY; FAMILIAL OVARIAN CANCER; INCESSANT OVULATION; ORAL CONTRACEPTIVES;
D O I
10.1002/cncr.2820710419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The only prophylaxis for ovarian cancer is oophorectomy, except in the very rare case when an ovarian cancer appears to arise from the mesothelial tissue of the abdominal cavity. It has been shown that women who have taken the oral contraceptive pill for 4 or 5 years decreases the incidence of ovarian cancer by approximately 40%. It is estimated that the oral contraceptive pill can prevent approximately 1500 ovarian cancers each year. The postmenopausal palpable ovary syndrome is simply the palpation of what is interpreted as a normal-sized ovary in the premenopausal woman represents an ovarian tumor in the postmenopausal woman. It addresses the size and consistency and has nothing to do with the small cysts reported by the sonographer. A patient who has two first-degree blood relatives or a mother, sister, or daughter who has developed ovarian cancer premenopausally is at high risk to develop ovarian cancer. Because ovarian cancer is the leading cause of death from gynecologic cancer, it is important to explore all options for prophylaxis in the prevention of ovarian cancer.
引用
收藏
页码:1529 / 1533
页数:5
相关论文
共 50 条
[31]   Reproductive factors, adiposity, breastfeeding and their associations with ovarian cancer in an Asian cohort [J].
Gay, Gibson Ming Wei ;
Lim, Jane Shu Ping ;
Chay, Wen Yee ;
Chow, Khuan Yew ;
Tan, Min Han ;
Lim, Wei-Yen .
CANCER CAUSES & CONTROL, 2015, 26 (11) :1561-1573
[32]   Screening for familial ovarian cancer - management and outcome of women with moderate to high risk of developing ovarian cancer [J].
Rieck, GC ;
Lim, K ;
Rogers, MT ;
France, E ;
Gray, JR ;
Amso, N ;
Evans, AS ;
Howells, RH ;
Fiander, AN .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 :86-91
[33]   The use of hormonal contraception and its protective role against endometrial and ovarian cancer [J].
Grimbizis, Grigoris F. ;
Tarlatzis, Basil C. .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2010, 24 (01) :29-38
[34]   What are the mechanisms of action of the different contraceptive methods to reduce the risk of ovarian cancer? [J].
Sanchez-Borrego, Rafael ;
Sanchez-Prieto, Manuel .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2021, 26 (01) :79-84
[35]   Ovarian cancer - from biology to clinic [J].
Kujawa, Katarzyna Aleksandra ;
Lisowska, Katarzyna Marta .
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69
[36]   Early Preinvasive Lesions in Ovarian Cancer [J].
Chene, Gautier ;
Lamblin, Gery ;
Le Bail-Carval, Karine ;
Chabert, Philippe ;
Bakrin, Naoual ;
Mellier, Georges .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[37]   The Chemoprevention of Ovarian Cancer: the Need and the Options [J].
Kathawala R.J. ;
Kudelka A. ;
Rigas B. .
Current Pharmacology Reports, 2018, 4 (3) :250-260
[38]   Prophylactic oophorectomy in ovarian cancer prevention [J].
Kontoravdis, A ;
Kalogirou, D ;
Antoniou, G ;
Kontoravdis, N ;
Karakitsos, P ;
Zourlas, PA .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1996, 54 (03) :257-262
[39]   Breastfeeding, menopause, and epithelial ovarian cancer [J].
Siskind, V ;
Green, A ;
Bain, C ;
Purdie, D .
EPIDEMIOLOGY, 1997, 8 (02) :188-191
[40]   Ovarian cancer: epidemiology and risk factors [J].
La Vecchia, Carlo .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2017, 26 (01) :55-62